135,241 Shares in Orthofix Medical Inc. $OFIX Purchased by Great Lakes Advisors LLC

Key Points

• Great Lakes Advisors bought 135,241 shares of Orthofix Medical, valued at approximately $1.24 million, giving it a 0.33% stake. Institutional investors collectively own 89.76% of the company.
• Analyst sentiment is mixed: three analysts rate OFIX a Buy, one rates it Hold, and one rates it Sell. The consensus rating is Hold, with a price target of $14.75 versus the stock’s recent price of $10.01.
• Orthofix reported quarterly revenue of $210.93 million and an adjusted loss of $0.39 per share, slightly exceeding expectations, but it continues to post negative profitability metrics and analysts expect a full-year loss of $1.29 per share.

Great Lakes Advisors LLC purchased a new stake in Orthofix Medical Inc. (NASDAQ:OFIX - Free Report) during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 135,241 shares of the medical device company's stock, valued at approximately $1,236,000. Great Lakes Advisors LLC owned about 0.33% of Orthofix Medical as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also recently bought and sold shares of the stock. Juniper Investment Company LLC increased its stake in shares of Orthofix Medical by 23.3% during the fourth quarter. Juniper Investment Company LLC now owns 3,510,333 shares of the medical device company's stock worth $53,217,000 after purchasing an additional 663,278 shares during the period. Engine Capital Management LP boosted its stake in Orthofix Medical by 3.2% in the 1st quarter. Engine Capital Management LP now owns 4,390,779 shares of the medical device company's stock valued at $50,362,000 after purchasing an additional 137,858 shares during the period. Global Strategic Investment Solutions LLC acquired a new position in Orthofix Medical in the 1st quarter valued at $664,000. Armistice Capital LLC grew its holdings in Orthofix Medical by 18.4% in the 4th quarter. Armistice Capital LLC now owns 2,648,000 shares of the medical device company's stock valued at $40,144,000 after buying an additional 412,000 shares in the last quarter. Finally, Counterpoint Mutual Funds LLC bought a new position in Orthofix Medical during the 1st quarter worth $261,000. 89.76% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently weighed in on the company. Canaccord Genuity Group dropped their target price on Orthofix Medical from $18.00 to $13.00 and set a "buy" rating for the company in a report on Monday, August 10th. Weiss Ratings restated a "sell (d-)" rating on shares of Orthofix Medical in a research note on Friday, July 17th. TD Cowen reaffirmed a "hold" rating on shares of Orthofix Medical in a research report on Thursday, May 21st. Wall Street Zen cut shares of Orthofix Medical from a "buy" rating to a "hold" rating in a research note on Saturday, May 2nd. Finally, Barrington Research boosted their price objective on shares of Orthofix Medical from $15.00 to $17.00 and gave the company an "outperform" rating in a report on Monday, July 6th. Three research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Hold" and a consensus price target of $14.75.

Orthofix Medical Price Performance

Shares of NASDAQ OFIX opened at $10.01 on Friday. The business has a fifty day moving average price of $10.62 and a two-hundred day moving average price of $11.48. The stock has a market capitalization of $407.71 million, a PE ratio of -6.50 and a beta of 0.68. The company has a debt-to-equity ratio of 0.55, a current ratio of 2.84 and a quick ratio of 1.67. Orthofix Medical Inc. has a fifty-two week low of $8.85 and a fifty-two week high of $16.99.

Orthofix Medical (NASDAQ:OFIX - Get Free Report) last issued its quarterly earnings results on Wednesday, August 5th. The medical device company reported ($0.39) EPS for the quarter, topping analysts' consensus estimates of ($0.41) by $0.02. The company had revenue of $210.93 million for the quarter, compared to analysts' expectations of $209.28 million. Orthofix Medical had a negative return on equity of 14.05% and a negative net margin of 7.41%. As a group, equities analysts predict that Orthofix Medical Inc. will post -1.29 earnings per share for the current fiscal year.

Insider Buying and Selling

In other Orthofix Medical news, insider Aviva Mcpherron sold 3,670 shares of the firm's stock in a transaction dated Thursday, June 18th. The shares were sold at an average price of $9.38, for a total value of $34,424.60. Following the transaction, the insider directly owned 66,330 shares of the company's stock, valued at $622,175.40. This trade represents a 5.24% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. 2.70% of the stock is currently owned by corporate insiders.

Orthofix Medical Profile

Orthofix Medical Inc NASDAQ: OFIX is a global medical device company focused on the design and development of innovative orthopedic and spinal solutions. The company's core business is divided into two segments: spine and orthopedics. In the spine segment, Orthofix offers a range of titanium implants, biologics and portable bone growth stimulation devices designed to support spinal fusion, deformity correction and minimally invasive procedures. Its orthopedic segment encompasses products for fracture fixation, external fixation systems, trauma care and sports medicine, providing surgeons with implantable devices and instruments for complex bone reconstruction and healing.

Orthofix's product portfolio includes strut systems, bone growth stimulators, interbody fusion devices and fixation hardware that address various indications such as degenerative disc disease, spinal deformities, non-unions and long-bone fractures.

Want to see what other hedge funds are holding OFIX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Orthofix Medical Inc. (NASDAQ:OFIX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source